The Government Accountability Office (GAO), a nonpartisan arm of Congress, recently uncovered serious, rampant problems in a government program that issued drug cards to Medicare beneficiaries. The cards were issued by insurance companies and pharmacy benefit managers (PBMs). The sponsors had contracts with the federal government, which approved their cards and regulated their operations.
The GAO's report highlighted the following issues:
In defense of the discount card program, Mark B. McClellan,MD, PhD, administrator of the Centers for Medicare and Medicaid Services, said that the problems have been addressed and "most submissions are now accurate."